Home
Loading

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

Get in touch

  • Contact

  • Request a demo

  • Request data updates

  • Add a company

Research

  • Companies

  • Investors

  • People

aVenture

  • Sitemap

  • Feature requests

Member

Backed by

© aVenture Investment Company, 2026. All rights reserved.

San Francisco, CA, USA

Privacy Policy

aVenture Investment Company ("aVenture") is an independent research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals. It is not a registered investment adviser, broker-dealer, or investment advisor and does not provide investment advice or recommendations. The data provided by aVenture does not constitute recommendations or advice, whether by methodology, analysis, AI-generated content, or a statement written by a staff member of aVenture.

aVenture is not affiliated with any of the people, companies, organizations, government agencies, regulatory bodies, or investment funds we provide coverage for on this site unless explicitly stated otherwise. Users assume full responsibility for decisions made based on information obtained from this platform. Links to external websites do not imply endorsement or affiliation with aVenture. Any links that provide the ability to invest in a primary or secondary transaction in a company are for convenience only and do not constitute solicitations or offers to buy or sell an investment. Investors should exercise heightened precaution and due diligence when investing in private companies, especially those not independently audited.

While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision. To the fullest extent permitted by law, aVenture shall not be liable for any direct, indirect, incidental, consequential, or financial damages arising from use of this site, whether by consumers of its contents directly or by persons or organizations covered by our research, even if we are advised of the possibility. Our best-efforts processes and correction request forms do not create a warranty or duty of care.

Profiles on this platform may include content generated in part by large language models (LLMs, artificial intelligence) that aggregate publicly available sources (e.g., SEC EDGAR, public filings, press releases). Source attribution is provided where known; always verify statements and claims here against original sources before relying on any data. Content on our site may contain inaccuracies, omissions, or what are commonly called 'hallucinations' if generated in part or in full by AI / LLMs. The risk can also exist even when content is written by a human, as internal and third-party sources may also have inaccuracies for the same or different reasons. While we randomly audit a proportion of content, this is not exhaustive.

We recommend that an independent auditor be hired to verify the accuracy of the information before relying on it for any sensitive decisions. By accessing this platform, you agree not to rely solely on any information generated by AI, aggregated, or sourced or written otherwise on this site, for investment, financial, or other decisions. aVenture assumes no responsibility for inaccuracies, omissions, or hallucinations. You must independently verify all data from primary sources. Use of this platform constitutes your waiver of claims for reliance-based damages, including negligent misrepresentation. To report an error, request a correction, or dispute information about a company or individual, contact us via our request data updates form.

Loading homepage
Loading
Home›Research›Companies

Companies

Loading
Home›
Research›
Companies›
Pyrls
AddedMar 17, 2024
UpdatedJul 7, 2026
Pyrls

Pyrls

Seed

Revolutionizing medical reference for providers with Pyrls app - prescribing, dispensing, educating patients. Trusted by 50,000+.

Founded
2020
Accelerator
Y Combinator logoY CombinatorW22
Overview
Compare
Fundraising
Employees
Website

Founded with the mission to revolutionize medical reference for healthcare providers, Pyrls offers a modern website and mobile app designed to enhance the prescribing, dispensing, and patient education processes. The platform is tailored for clinicians, including pharmacists, physicians, nurse practitioners, and other healthcare professionals. Pyrls aims to simplify and improve the management of clinical practice information, making key drug data easily accessible and understandable.

Notably trusted by over 50,000 clinicians and trainees, Pyrls has garnered significant adoption within the healthcare community. The platform's impact is evident through its widespread use across hundreds of organizations. By providing an intuitive and reliable resource for drug information, Pyrls is shaping the future of clinical practice management and education, ultimately contributing to better patient care and more efficient healthcare delivery.

Pyrls - Similar Companies

MedMe Health logo

MedMe Health

medmehealth.com

InpharmD logo

InpharmD

inpharmd.com

Prescribe logo

Prescribe

Mednet logo

Mednet

themednet.org

DrFirst.com logo

DrFirst.com

drfirst.com

Pillar logo

Pillar

withpillar.com

eazyScripts logo

eazyScripts

eazyscripts.com

MediPocket logo

MediPocket

RxVantage logo

RxVantage

rxvantage.com

RxLive logo

RxLive

rxlive.com

Mederva Health logo

Mederva Health

medervahealth.com

Clinikally logo

Clinikally

clinikally.com

Pemrs logo

Pemrs

emr4me.com

RxApps logo

RxApps

ScriptPad logo

ScriptPad

Pyrls - Quick Facts

Who are Pyrls' competitors?

Companies similar to Pyrls include MedMe Health, InpharmD, Prescribe and Mednet.

When was Pyrls founded?

Pyrls was founded in 2020.

When was Pyrls' last funding round?

Pyrls' most recent funding round was for $500k (USD) in January 2022.

How much has Pyrls raised to-date?

As of Jan 1, 2022, Pyrls has raised a total of $500k (USD).

How many employees does Pyrls have?

Pyrls has 3 employees as of Mar 19, 2024.

Pyrls - Classification

Ownership
  • Private
  • Venture Capital
Technology
  • Telemedicine
Geographic Exposure
  • Global
Model
  • Platform
Revenue
  • Recurring
  • Software
  • Subscription
Customer
  • Enterprise
Main Product
  • Medical Reference
Tags
  • Healthtech
  • SaaS